PicoCELA, Inc. ADR ( ($PCLA) ) just unveiled an announcement. On December 29, 2025, PicoCELA Inc. held its annual general meeting of shareholders ...

At the Special Meeting of Stockholders held on December 5, 2025, the Company’s stockholders approved a reverse stock split of ...

PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, ...

The reverse split is intended to help PAVmed comply with Nasdaq’s $1.00 minimum bid price requirement to maintain its listing on the exchange. The company’s board approved the ratio on December 8, ...

Following the split, every 35 shares of common stock will be automatically reclassified into one new share, while the par value will remain unchanged at $0.001 per share. No fractional shares will be ...

SAN DIEGO, CA, Dec. 30, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL” or the "Company”) today announced that ...

Adicet Bio, Inc. is a clinical-stage biotechnology company focused on discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, advancing an “off‑the‑shelf ...

Under the consolidation plan, 10 equity shares of face value Rs 1 each will be consolidated into 1 equity share of face value ...

Intelligent Living Application Group Inc. (Nasdaq: ILAG) (the "Company" or "Intelligent Living"), a premium lockset manufacturer ...

Shares of Aptevo Therapeutics Inc. (NASDAQ: APVO) are trading lower Friday after the Seattle-based company announced a ...

Investing.com -- Adicet Bio Inc (NASDAQ:ACET) stock fell 9.2% in premarket trading Friday after the clinical-stage biotechnology company announced a 1-for-16 reverse stock split to regain compliance ...

The Reverse Stock Split was approved by the Company's stockholders at the Company's Annual Meeting of Stockholders held on July 24, 2025 (the "Annual Meeting") to be effected in the Board's discretion ...